InvestSMART

Medibio Limited (ASX: MEB) - Announcements

- Current share price for MEB : $0.001

ASX company news and announcements for Medibio Limited (MEB) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Medibio Limited (MEB) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Medibio Limited (MEB), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Medibio Limited (MEB)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$6 Appendix 4C - quarterly & Operations report 31 Jul 2015 7:02PM $0.380 $0.001 fallen by 99.74%
$6 Investor Presentation to be used in a series of US presentat 21 Jul 2015 8:26AM $0.320 $0.001 fallen by 99.69%
$6 Provisional Patent for improved objective diagnostic for dep 15 Jul 2015 9:48AM $0.340 $0.001 fallen by 99.71%
$6 Investor Update 10 Jul 2015 9:49AM $0.330 $0.001 fallen by 99.70%
$6 Disclosure Document - Notice under Section 708A 10 Jul 2015 9:33AM $0.330 $0.001 fallen by 99.70%
$6 Appendix 3B 10 Jul 2015 9:29AM $0.330 $0.001 fallen by 99.70%
$6 MEB lodges provisional patents covering stress breakthrough 2 Jul 2015 9:54AM $0.300 $0.001 fallen by 99.67%
$6 Ground-breaking test for the measurement of stress & impact 17 Jun 2015 9:47AM $0.310 $0.001 fallen by 99.68%
$6 Strategic Device Partnership 28 May 2015 10:08AM $0.300 $0.001 fallen by 99.67%
$6 Medibio Investor Presentation May 2015 20 May 2015 11:19AM $0.320 $0.001 fallen by 99.69%
$6 MEB processes first participant in Black Dog Institute 11 May 2015 9:41AM $0.340 $0.001 fallen by 99.71%
$6 Appendix 4C - quarterly 30 Apr 2015 7:22PM $0.300 $0.001 fallen by 99.67%
$6 MEB acquires the US & Canadian Circadain Heart Rate patents 21 Apr 2015 9:35AM $0.310 $0.001 fallen by 99.68%
$6 Investor Presentation 20 Apr 2015 8:28AM $0.300 $0.001 fallen by 99.67%
$6 Completion of Share Consolidation 20 Mar 2015 4:09PM $0.325 $0.001 fallen by 99.69%
$6 Half Yearly Report and Accounts 27 Feb 2015 5:48PM $0.300 $0.001 fallen by 99.67%
$6 Commercialization Study confirm revenue opportunity 6 Feb 2015 10:15AM $0.003 $0.001 fallen by 66.67%
$6 Appendix 4C - quarterly 30 Jan 2015 5:46PM n/a $0.001 n/a
$6 Medibio appoints US based CRO for its validation trials 5 Dec 2014 10:05AM $0.003 $0.001 fallen by 66.67%
$6 Reinstatement to Official Quotation 1 Dec 2014 10:12AM n/a $0.001 n/a

601 - 620 of 620 results

Page 25 of 25

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.